Share
The Myeloma Survival Guide: Essential Advice for Patients and Their Loved Ones, Second Edition (in English)
Jim Tamkin
(Author)
·
Dave Visel
(Author)
·
Demos Medical Publishing
· Paperback
The Myeloma Survival Guide: Essential Advice for Patients and Their Loved Ones, Second Edition (in English) - Tamkin, Jim ; Visel, Dave
$ 17.47
$ 24.95
You save: $ 7.49
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Monday, May 20 and
Tuesday, May 21.
You will receive it anywhere in United States between 1 and 3 business days after shipment.
Synopsis "The Myeloma Survival Guide: Essential Advice for Patients and Their Loved Ones, Second Edition (in English)"
The Myeloma Survival Guide makes sense of the difficult questions myeloma patients face, dealing with every aspect of life after diagnosis, from creating a wellness team to navigating treatment options to building a financial safety net. Jim Tamkin, MD, who lived with myeloma for 11 years, and Dave Visel share the insights they've gained as a doctor, patient, and caregiver, including: Everything you need to know about drugs and treatments, including stem cell transplantsHow to deal with the pain and side effects of chemotherapy, radiation, and surgeryInsurance and tax benefits to save money and get you the care you deserveTake-charge tools you can use today to feel better tomorrowThe second edition has been thoroughly updated and includes a new chapter on pills and medical adherence."An invaluable guide to patients with newly diagnosed multiple myeloma. Not only have they provided clear information on the disease and its treatment, but most importantly also convey critical guidance on how to deal with the very personal life-impacting effects of this disease for patients and family members alike."-- Kenneth C. Anderson, MD, Kraft Family Professor of Medicine, Harvard Medical School, and Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute
